-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels' In Vitro Killing Experimental Platform: An Innovative Tool to Uncover the Mechanisms of Cytotoxicity
Author:
InnoModels
Release time:
2024-04-16
With the further development of biomedicine, the study of cytotoxicity mechanism has become more and more important. In this field, the in vitro killing experiment platform of InnoModels has become an innovative tool to reveal the mechanism of cytotoxicity by virtue of its unique features.
1. Highly simulate the real environment
The in vitro killing experimental platform of InnoModels focuses on simulating the environment of real organisms, including interactions between cells and interactions between cells and the microenvironment, etc. This high degree of simulation makes the results of the experiments more effective. This high degree of simulation makes the experimental results more credible, better reflecting the actual situation and providing more accurate data support for the study of cytotoxicity mechanism.
2、Diversified killing models
The in vitro killing experimental platform of InnoModels provides diversified killing models, including but not limited to drug killing, radiation killing, immunocide killing, etc. These models can meet different research needs, and can be used for the study of cytotoxicity. These models can meet different research needs and provide researchers with more comprehensive information on cytotoxicity mechanisms. Meanwhile, the platform also supports the customization of personalized models to meet special research needs.

3、High-throughput processing capability
In cytotoxicity mechanism research, a large number of samples and data need to be processed. The in vitro killing experimental platform of InnoModels Biotechnology is equipped with high-throughput processing capability, which is able to process multiple samples in a short period of time and generate experimental results quickly. This efficient processing capability not only improves research efficiency, but also provides strong support for large-scale drug screening and toxicity assessment.
4、Precise experimental control
The study of cytotoxicity mechanism requires precise experimental control to ensure the reliability of experimental results. The in vitro killing experimental platform of InnoModels adopts an advanced experimental control system, which can precisely control the experimental conditions, including the number of cells, drug concentration, treatment time and so on. This precise experimental control helps to reduce errors and improve the accuracy and reliability of experimental results.
5. Wide range of application fields
The in vitro killing experimental platform of InnoModels Biotechnology has a wide range of applications in the fields of drug research and development, toxicity assessment, and immunology research. Through this platform, researchers can gain a deeper understanding of the toxicity mechanism of drugs on cells and assess the safety of drugs; at the same time, they can also study the killing mechanism of immune cells on pathogens and provide new ideas and methods for the treatment of diseases.
In conclusion, the in vitro killing experimental platform of InnoModels Biotechnology provides powerful support for revealing the mechanism of cytotoxicity with its high simulation of the real environment, diversified killing models, high-throughput processing capability, precise experimental control, and a wide range of application areas. With the continuous progress of technology and the expansion of application fields, the platform is expected to play a greater role in biomedical research and promote the development and progress of the biomedical field.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd